Companies
6,643
Clinical Trials
1,190
FDA Companies
1,603
Products
0
Signals
2,793
Sources
2
🔥 Top Opportunity Companies
Latest Companies
Novartis
company_website
Amplia Therapeutics
clinicaltrials
Samsung Pharmaceutical
clinicaltrials
Iregene Therapeutics
clinicaltrials
Nora Therapeutics
clinicaltrials
Penwest Pharmaceuticals
clinicaltrials
Airway Therapeutics
clinicaltrials
Emergo Therapeutics
clinicaltrials
Opportunity Trend
Data Sources
Latest Clinical Trials
| # | Company | Study | Phase | Status | Sponsor | Updated | Action |
|---|---|---|---|---|---|---|---|
| 1 | Jeil Pharmaceutical |
JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD
NCT07115706
|
Unknown | NOT YET RECRUITING | Jeil Pharmaceutical Co., Ltd. | 92d ago | View |
| 2 | Vifor Pharma |
EVIdence Based TreAtment - Heart Failure (EVITA-HF)
NCT01057004
|
Unknown | COMPLETED | Stiftung Institut fuer Herzinfarktforschung | 92d ago | View |
| 3 | Vifor Pharma |
Hyperkalaemia and Its Impact on Therapy with RAASi
NCT04249648
|
Unknown | COMPLETED | Portsmouth Hospitals NHS Trust | 92d ago | View |
| 4 | Vifor Pharma |
The German Patient Blood Management Network
NCT02147795
|
Unknown | UNKNOWN | Johann Wolfgang Goethe University Hospital | 92d ago | View |
| 5 | Mundipharma Research |
Rezafungin Peritoneal Diffusion for Intra-abdominal Candidiasis
NCT07093203
|
Unknown | RECRUITING | Central Hospital, Nancy, France | 92d ago | View |
| 6 | Mundipharma Research |
The Impact of Opioids in Fractures - a Case Control Study
NCT02090972
|
Unknown | COMPLETED | Ruhr University of Bochum | 92d ago | View |
| 7 | Mundipharma Research |
The Impact of Opioids in Coronary Heart Disease
NCT02740621
|
Unknown | COMPLETED | Ruhr University of Bochum | 92d ago | View |
| 8 | Amsterdam Molecular Therapeutics |
Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal "Pancreatitis" Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies
NCT01448577
|
Unknown | UNKNOWN | Amsterdam Molecular Therapeutics | 92d ago | View |
| 9 | Intellia Therapeutics |
Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002
NCT06262399
|
Unknown | ENROLLING BY INVITATION | Intellia Therapeutics | 92d ago | View |
| 10 | Incyte Biosciences International Sàrl |
Vitiligo Registry for Adults and Children in the UK
NCT06218082
|
Unknown | NOT YET RECRUITING | The Royal Wolverhampton Hospitals NHS Trust | 92d ago | View |
Recent Discovery Activity
>
Novartis
Updated
8/19/2026
>
Amplia Therapeutics
Updated
7/27/2026
>
Samsung Pharmaceutical
Updated
7/27/2026
>
Iregene Therapeutics
Updated
7/27/2026
>
Nora Therapeutics
Updated
7/27/2026
>
Penwest Pharmaceuticals
Updated
7/27/2026
>
Airway Therapeutics
Updated
7/27/2026
>
Emergo Therapeutics
Updated
7/27/2026
>
Neurogenetic Pharmaceuticals
Updated
7/27/2026
>
Sichuan Baili Pharmaceutical
Updated
7/27/2026
Today's Intelligence
🏢 0
new companies discovered today
🧪0
clinical trials updated today